Références utilisées pour le contenu de cette section
- ESC. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Available from: https://www.escardio.org/.
- Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe. Thromb Haemost. 2007;98:756-764.
- Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Bio.l 2014;34:2363-2371.
- Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118:1340-1347.
- Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41:522 – 529.
- Mai V, Guay CA, Perreault L, et al. Extended Anticoagulation for VTE. Chest J. 2019;155(6): 1200-1216.
- Gottschalk A, Stein P, Goodman L, et al. Overview of Prospective Investigation of Pulmonary Embolism Diagnoses II. Seminars in Nuclear Medicine. 2002;32(3): 173-182.
- Perkins G, Olasveengen T, Maconochie I, et al. European Resuscitation Council Guidelines for Resuscitation: 2017 update. Elsevier. 2018;123:43-50.
- Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144:165–171.
- Van Es N, Coppens M, Schulman S, et al. Direct oral anticoagulants compared with vitamin K antagonists for acute symptomatic venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12): 1968–1975.
- Mai V, Tanguay VF, Guay CA, et al. DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020;50(3):661-667.